OncoSil Medical Limited
OncoSil Medical Limited
Explore linked clinical trials.3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| FOLFIRINOX Versus OncoSil™ in Addition to FOLFIRINOX in Patients With Locally Advanced Pancreatic Adenocarcinoma | Locally Advanced Pancreatic Cancer | Active, not recruiting | Phase 2 | 2026-02-13 | NCT05466799 | |
| OncoSil Pancreatic Cancer Post-marketing Clinical Registry - Italy | Locally Advanced Pancreatic Adenocarcinoma | Not yet recruiting | Not stated | 2024-05-03 | NCT06399172 | |
| OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry. | Digestive System Diseases, Digestive System Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Not stated | 2024-04-30 | NCT04493632 |